Abstract
A commentary on "Association of glucagon-like peptide-1 receptor agonists with risk of cancers-evidence from a drug target Mendelian randomization and clinical trials" (Int J Surg. 2024 May 3.).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have